SUBCUTANEOUS AS REQUIRED & SYRINGE PUMP PRESCRIPTION & ADMINISTRATION RECORD (SPAR) Name: Address: Postcode: Date of Birth: NHS Number:

Size: px
Start display at page:

Download "SUBCUTANEOUS AS REQUIRED & SYRINGE PUMP PRESCRIPTION & ADMINISTRATION RECORD (SPAR) Name: Address: Postcode: Date of Birth: NHS Number:"

Transcription

1 FILE IN PATIENT S COMMUNITY HEALTH RECORD FOLDER : SUBCUTANEOUS AS REQUIRED & SYRINGE PUMP PRERIPTION & ADMINISTRATION RECORD (SPAR) Abbreviations used in this document to be listed here with the full description CI Continuous subcutaneous infusion JiCD Just in case four core drugs PRN As required PO By mouth Subcutaneously SPAR Subcutaneous as required & syringe pump prescription & administration record STAT Immediately Address: General Practitioner Important Contacts : Address: Write patient details or affix Identification label Hospital Number: : Address: Postcode: Date of Birth: NHS Number: Syringe pump serial code: SPAR booklet number: (Circle relevant number above) Next of Kin Telephone number: : Address: Telephone number: District Nurse Telephone number: Specialist Palliative Care Advice Line For Blackpool, Fylde and Wyre: Trinity Hospice on (24 hours) For Lancaster, Morecambe and Carnforth: St John s Hospice, Hospice at home hub (24hours) RELEVANT ALLERGIES/DRUG SENSITIVITIES or STATE NO KNOWN ALLERGIES JUST IN CASE 4 CORE DRUGS (JiCD) DRUG Morphine Levomepromazine Midazolam Glycopyrronium Water for Injection QUANTITY SUPPLIED 5 x 10 mg/ml 5 x 25 mg/ml 5 x 10 mg/2 ml 5 x 200 microgram/ml 10 x 10 ml When pack opened, state if any discrepancies found between supplied and checked quantities, and reasons for discrepancy Date JiCD Bag opened & contents checked District Nurse ( Print ) QUANTITY CHECKED (initial) District Nurse Signature Expiry date PRERIPTION RECORDS PAGE DRUG Date started Date stopped 6 7 Water for Injection 8 9 Morphine Midazolam Levomepromazine Glycopyrronium Alternative opioid Non 4 core drug prescription Specialist medication Specialist medication SPAR version 8.0 (October 2018) Review due September 2021 Pharmacist check: : Signature: VS2142 Approved by the Health Records Consultation Group Procedural Document ID: CORP/PROC/592

2 JUST IN CASE FOUR CORE DRUGS (JiCD) Anticipatory Prescribing for End of Life Care The provision of JiCD at the end of life can support proactive symptom control by promoting anticipatory prescribing, which ensures common symptoms are anticipated and responded to in a timely fashion. Patients may be prescribed different end of life drugs anticipatory medications if they are intolerant of these recommended first line medications. For further information, please contact local Specialist Palliative Care Team for advice. Pain Nausea and Vomiting Agitation and Restlessness Respiratory Tract Secretions Morphine 10 mg/ml *Supply: 5 x 1mL Levomepromazine 25 mg/ml *Supply: 5 x 1mL Midazolam 10 mg/2ml *Supply: 5 x 2mL Glycopyrronium 200 micrograms/ml *Supply: 5 x 1mL Initial PRN dose **2.5 mg 1 hourly PRN Initial PRN dose 2.5mg mg 6 hourly PRN Initial PRN dose 2.5mg - 5 mg 4 hourly PRN Initial PRN dose 200 micrograms 4 hourly PRN Initial CI dose **5-10 mg over 24 hours Initial CI dose 6.25mg mg over 24 hours Initial CI dose 5mg - 10mg over 24 hours Initial CI dose 0.6mg mg Over 24 hours Water for Injections 10 x 10 ml (to dilute CI to a volume of at least 10mL ideally to maximum 17mL in a 20mL syringe or to maximum 22mL in a 30mL syringe) Dilution can be brand specific so always check * These quantities have been designed to cover the longest possible scenario of being needed over a bank holiday weekend, so please ensure adequate amount prescribed to ensure supply for 5 days (usually at least enough for 2 doses per day). ** For patients established on oral morphine or oxycodone, follow guidance on page 3 for conversion of oral to equivalent subcutaneous dose. For patients on buprenorphine or fentanyl patches, follow guidance on page 3 and discuss with Specialist Palliative Care Service for advice regarding further analgesia (see page 1 for contact numbers). If a patient is receiving an alternative opioid, discuss with Specialist Palliative Care Service for advice.. 2

3 PAIN MANAGEMENT If the patient has moderate to severe renal impairment (Chronic Kidney Disease 4 i.e. egfr of 30mL/min or less), discuss with the Specialist Palliative Care Service for advice regarding further analgesia. If the patient is on a buprenorphine or fentanyl patch, leave the patch in situ, change as usual and discuss with the Specialist Palliative Care Service for advice regarding further analgesia For opioid naïve patients or those established on oral morphine Yes Is the patient taking oral morphine? No Stop oral morphine Convert to a 24 hour CI of morphine, by dividing the total daily dose of oral morphine by 2 e.g. Yes Patient in pain? No Total daily oral CI morphine morphine dose 60 mg 30 mg Prescribe a rescue dose of morphine 1 hourly PRN. (Dose should be 1/6th of the calculated total CI morphine dose.) Consider giving morphine 2.5 mg Consider starting CI with morphine 5mg - 10 mg over 24 hours Rescue dose of morphine 2.5 mg 1 hourly PRN ENSURE PRN morphine 2.5 mg 1 hourly prescribed Titrate dose as necessary; discuss with the Specialist Palliative Care Service if pain not controlled on 60 mg morphine over 24 hours. For patients who are opioid naïve but need oxycodone such as patients with significant renal impairment (GFR 30mL/min or less) Use rescue oxycodone dose 1.25mg - 2.5mg 4 hourly PRN. Consider starting a CI with oxycodone 5mg - 10mg over 24 hours if frequent episodes of pain For patients established on oral oxycodone Follow the initial steps of the algorithm for morphine. Convert oral oxycodone to dose as shown below Stop regular oral oxycodone Use a 3:2 conversion to determine the oral: CI dose Divide the oral dose by 1.5 to obtain the CI dose Total daily oral oxycodone CI oxycodone dose 40 mg 25 mg Prescribe a rescue dose of oxycodone 1 hourly PRN. (Dose should be a 1/6th of the calculated total CI oxycodone dose.) Titrate dose as necessary; discuss with the Specialist Palliative Care Service if pain not controlled on 60 mg oxycodone over 24 hours. *Some references recommend a 2:1 conversion from oral to subcutaneous oxycodone. For end of life care use the value of 3:2 as shown above. 3

4 NAUSEA AND VOMITING If the symptoms are not controlled on levomepromazine 25 mg over 24 hours, contact the Specialist Palliative Care Service for advice. Yes Is the patient nauseated? No Consider giving levomepromazine 2.5mg mg (Use clinical judgement as to dose) Consider CI levomepromazine 6.25mg mg over 24 hours Titrate as needed to max 25 mg over 24 hours ENSURE PRN levomepromazine 2.5mg mg 6 hourly prescribed (Use clinical judgement as to dose) AGITATION AND TERMINAL RESTLESSNESS If patient remains restless on midazolam 30 mg over 24 hours, contact the Specialist Palliative Care Service for advice Yes Agitation/restlessness No Exclude reversible causes: Constipation Urinary retention Nicotine withdrawal ENSURE PRN midazolam 2.5mg - 5 mg 4 hourly prescribed Consider midazolam 2.5mg - 5 mg Consider CI midazolam 5mg - 10 mg over 24 hours If starting CI above 10mg over 24 hours, seek specialist advice. Titrate dose as necessary up to a max 30 mg over 25 hours. Max dose 60 mg (on specialist advice) over 24 hours 4

5 RESPIRATORY TRACT SECRETIONS If the symptoms are not controlled, contact the Specialist Palliative Care Service for advice. Treatment must be started as soon as symptoms appear. Drugs cannot remove already-present secretions. Consider positional change or use of suction. Yes Secretions present? No Consider stat glycopyrronium 200 micrograms Consider CI glycopyrronium 0.6mg mg over 24 hours Titrate dose as necessary; max dose 1.2 mg over 24 hours. If requires higher dose, seek specialist advice. ENSURE PRN glycopyrronium 200 micrograms 4 hourly prescribed OTHER DRUGS THAT MAY BE USED IN CIs LOCALLY INCLUDE: Drug Dose Indication Diamorphine If opioid naïve: 5 10 mg/24 hour Pain (reserved for high doses) Oxycodone If opioid naïve: 5 10 mg/24 hour Pain Hyoscine butylbromide (Buscopan) mg/24 hour Gastrointestinal colic/respiratory (Higher doses may be used on specialist advice) tract secretions Metoclopramide 30 mg/24 hour (Higher doses on specialist advice) Nausea & vomiting Haloperidol mg/24 hour (max 10mg/24 hour) Nausea & vomiting (Haloperidol 5 30 mg/24 hour Agitation) Cyclizine mg/24 hour (max 150 mg/24 hour) Nausea & vomiting Hyoscine Hydrobromide mg/24 hour (max 2.4 mg/24 hour) Respiratory tract secretions Sodium chloride 0.9% for injection not with cyclizine Diluent THE FOLLOWING DRUGS ARE TO BE USED ONLY ON THE RECOMMENDATION OF SPECIALIST PALLIATIVE CARE Levomepromazine 25 75mg/24 hour Agitation/Delirium (Higher doses may be used on specialist advice) Octreotide micrograms/24 hour Obstructive vomiting Ondansetron 8 24 mg/24 hour (max 32 mg/24 hour) Refractory vomiting Tramadol mg/24 hour Pain Dexamethasone 2mg 16 mg/24 hour Multiple uses, e.g. pain, nausea THE FOLLOWING DRUGS ARE TO BE USED ONLY WITH THE DIRECT GUIDANCE OF A SPECIALIST IN PALLIATIVE CARE Alfentanil Ketorolac Pain Methadone Levetiracetam (Keppra) Epileptic Seizures Sodium Valproate Compatibility of Medicines in a Syringe Pump Always base the prescription of the medication in the syringe pump on a face to face clinical assessment of the patient and their current symptoms. Most patients do not need all 4 Just in case drugs in a syringe pump in order to keep them comfortable. The four core drugs recommended in this guidance are compatible to be used together in a syringe pump. Other drugs may or may not be compatible for use together. An online syringe pump compatibility tool is available at If unsure, please seek further advice from local specialist palliative care team or hospice advice line. 5

6 Hospital number: Patient date of birth: For continuous subcutaneous infusion via syringe pump PLEASE SIGN FOR ALL PATIENTS IN ANTICIPATION OF THE NEED TO SET UP A SYRINGE PUMP OUT OF HOURS Date Medication Dosage Frequency Print Signature AS REQUIRED 24 HOURS Date Time of Drug DRUG ADMINISTRATION AND STOCK CONTROL RECORD & Exp Date Initial Print Print 6

7 Date Time of Drug & Exp Date Initial Print Print 7

8 : JUST IN CASE PRERIPTION FOR A PATIENT NOT ON OR OTHER OPIOID FOR PAIN Date Medication Dosage Frequency Print Signature (Just in Case Prescription) If opioid naïve: 2.5mg Hourly STAT PRN for pain : JUST IN CASE PRERIPTION DOSE AND AS REQUIRED DOSE IF ALREADY ON OPIOIDS - AIM to PRERIBE 1/6 th of the 24 hour dose : FOR CONTINUOUS SUBCUTANEOUS INFUSION VIA SYRINGE PUMP IF NOT ON OR OTHER OPIOIDS FOR PAIN Date Medication Dosage Frequency Print Signature If opioid naïve: 5mg 10 mg 24 HOURS or : CONTINUOUS SUBCUTANEOUS INFUSION DOSE RANGE OVER 24 HOURS IF ALREADY ON OPIOID Dose ranges prescribed should be clinically appropriate but no bigger than a 50% dose increase between the lower dose and the higher dose. New dose ranges should be rewritten in a new box and previous dose range discontinued 24 HOURS 24 HOURS 24 HOURS 24 HOURS 24 HOURS 24 HOURS 24 HOURS 8

9 Date Time of Drug Strength of CONTROLLED DRUG ADMINISTRATION AND STOCK CONTROL RECORD & Exp Date Initial Dose Given 9

10 : JUST IN CASE PRERIPTION AND FOR USAGE AS REQUIRED Date Medication Dosage Frequency Print Signature (prescriber) (Just in Case Prescription) 2.5mg - 5mg 4 hourly STAT PRN for agitation & restlessness : FOR CONTINUOUS SUBCUTANEOUS INFUSION VIA SYRINGE PUMP Date Medication Dosage Frequency Print Signature 5mg 10mg 24 HOURS 24 HOURS 24 HOURS 24 HOURS 24 HOURS CONTROLLED DRUG ADMINISTRATION AND STOCK CONTROL RECORD Date Time of Drug Strength of & Exp Date Initial Dose Given 10

11 Date Time of Drug Strength of CONTROLLED DRUG ADMINISTRATION AND STOCK CONTROL RECORD & Exp Date Initial Dose Given Print Print 11

12 : JUST IN CASE PRERIPTION AND FOR USAGE AS REQUIRED Date Medication Dosage Frequency Print Signature (Just in Case Prescription) 2.5 mg mg 6 Hourly STAT PRN for nausea & vomiting : FOR CONTINUOUS SUBCUTANEOUS INFUSION VIA SYRINGE PUMP Date Medication Dosage Frequency Print Signature 6.25mg 12.5 mg 24 HOURS 24 HOURS 24 HOURS 24 HOURS 24 HOURS DRUG ADMINISTRATION AND STOCK CONTROL RECORD Date Time of Drug Strength of & Exp Date Initial Dose Given Print Print 12

13 DRUG ADMINISTRATION AND STOCK CONTROL RECORD cont Date Time of Drug Strength of & Exp Date Initial Dose Given Print Print 13

14 : JUST IN CASE PRERIPTION AND FOR USAGE AS REQUIRED Date Medication Dosage Frequency Print Signature (Just in Case Prescription) 200 micrograms (0.2mg) 4 hourly STAT PRN for respiratory secretions : FOR CONTINUOUS SUBCUTANEOUS INFUSION VIA SYRINGE PUMP Date Medication Dosage Frequency Print Signature 0.6mg 1.2mg 24 HOURS 24 HOURS 24 HOURS 24 HOURS 24 HOURS Date Time of Drug Strength of DRUG ADMINISTRATION AND STOCK CONTROL RECORD & Exp Date Initial Dose Given Print Print 14

15 DRUG ADMINISTRATION AND STOCK CONTROL RECORD cont Date Time of Drug Strength of & Exp Date Initial Dose Given Print Print 15

16 PRERIPTION OF ALTERNATIVE STRONG OPIOID AS REQUIRED JUST IN CASE Date Medication Dosage Frequency Print Signature ALTERNATIVE STRONG OPIOID FOR CONTINUOUS SUBCUTANEOUS INFUSION VIA SYRINGE PUMP Dose ranges prescribed should be clinically appropriate but no bigger than a 50% dose increase between the lower dose and the higher dose. New dose ranges should be rewritten in a new box and previous dose range discontinued Date Medication Dosage Frequency Print Signature 24 HOURS 24 HOURS 24 HOURS 24 HOURS 24 HOURS CONTROLLED DRUG ADMINISTRATION AND STOCK CONTROL RECORD Date Time of Drug Strength of & Exp Date Initial Dose Given 16

17 CONTROLLED DRUG ADMINISTRATION AND STOCK CONTROL RECORD cont Date Time of Drug Strength of & Exp Date Initial Dose Given 17

18 END OF LIFE DRUG PRERIPTION RECORD FOR MEDICATION OTHER THAN THE JUST IN CASE FOUR CORE DRUGS NAME OF MEDICATION SYMPTOM BEING MANAGED Dose range (mg) FOR USAGE AS REQUIRED ONLY Date Medication Dosage Frequency Print Signature (Prescriber) FOR CONTINUOUS SUBCUTANEOUS INFUSION VIA SYRINGE PUMP Date Medication Dosage Frequency Print 24 HOURS 24 HOURS 24 HOURS 24 HOURS Signature (Prescriber) Date Time of Drug Strength of DRUG ADMINISTRATION AND STOCK CONTROL RECORD & Exp Date Initial Dose Given HCP 2(if applicable) 18

19 DRUG ADMINISTRATION AND STOCK CONTROL RECORD cont Date Time of Drug Strength of & Exp Date Initial Dose Given 19

20 SPECIALIST PALLIATIVE CARE PRERIPTION RECORD Date Medication Symptom(s) being managed Dose range (mg) Indication for increase in dose Size of incremental dose (mg) Time between each increase in dose (days) ADDITIONAL COMMENTS SIGNIFICANT ADVERSE EFFECTS OF MEDICATION TO BE AWARE OF: SPECIALIST LEAD (Print ) CONTACT NUMBER PRERIBED BY (Print name) SIGNATURE & DATE If ceiling dose is being approached, or patient experiences significant adverse effects, please contact Trinity Hospice to discuss next steps. During weekdays ring and ask to speak to the doctor on call for clinical advice. Out of hours or at weekends please phone in patient unit and speak to the nurse in charge. FOR USAGE AS REQUIRED SEE ADVICE ABOVE Date Medication Dosage Frequency Print FOR CONTINUOUS SUBCUTANEOUS INFUSION VIA SYRINGE PUMP SEE ADVICE ABOVE Signature (Prescriber) Date Medication Dosage Frequency Print Signature 24 HOURS 24 HOURS 24 HOURS 24 HOURS 20

21 DRUG ADMINISTRATION AND STOCK CONTROL RECORD Date Time of Drug Strength of & Exp Date Initial Dose Given 21

22 SPECIALIST PALLIATIVE CARE PRERIPTION RECORD Date Medication Symptom(s) being managed Dose range (mg) Indication for increase in dose Size of incremental dose (mg) Time between each increase in dose (days) ADDITIONAL COMMENTS SIGNIFICANT ADVERSE EFFECTS OF MEDICATION TO BE AWARE OF: SPECIALIST LEAD (Print ) CONTACT NUMBER PRERIBED BY (Print name) SIGNATURE & DATE If ceiling dose is being approached, or patient experiences significant adverse effects, please contact Trinity Hospice to discuss next steps. During weekdays ring and ask to speak to the doctor on call for clinical advice. Out of hours or at weekends please phone in patient unit and speak to the nurse in charge FOR USAGE AS REQUIRED SEE ADVICE ABOVE Date Medication Dosage Frequency Print FOR CONTINUOUS SUBCUTANEOUS INFUSION VIA SYRINGE PUMP SEE ADVICE ABOVE Date Medication Dosage Frequency Print 24 HRS 24 HRS 24 HRS 24 HRS Signature (Prescriber) Signature (Prescriber) 22

23 DRUG ADMINISTRATION AND STOCK CONTROL RECORD Date Time of Drug Strength of & Exp Date Initial Dose Given 23

24 Community Pharmacies Participating in Anticipatory Supply of JiCD in Tamper Evident Bag Blackpool Cohens Pharmacy Moor Park Health Centre Bristol Avenue Blackpool FY2 0JG Telephone Mon-Fri Sat Sun Blackpool MedicX Pharmacy Whitegate Primary Care Centre 150 Whitegate Drive Blackpool FY3 9ES Telephone Mon-Sun Blackpool Co-op Pharmacy Cleveleys/ Thornton Boots Pharmacy 9 11 All Hallows Road Bispham Blackpool FY2 0AS Telephone Mon-Fri Sat Victoria Road Cleveleys, FY5 1BS Telephone Blackpool Lytham Road Pharmacy Kirkham Co-op Pharmacy South Shore Primary Care Centre Lytham Road Blackpool FY4 1TJ Telephone Mon - Thur Fri Market Square, Kirkham PR4 2SD Telephone Mon-Sat Sun Mon-Fri Sat Fleetwood Warburtons Pharmacy Lord Street Fleetwood FY7 6JZ Telephone Poulton/Carleton Carleton Pharmacy 5 Poulton Road Carleton FY6 7NH Telephone Freckleton Well Pharmacy Great Eccleston Great Eccleston Health Centre ThePharmacy Mon-Fri Sat Douglas Drive Health Centre Freckleton PR4 1RY Telephone Mon-Fri Sat Raikes Road Great Eccleston PR3 0ZA Telephone St Anne s/lytham MedicX Pharmacy Hambleton Hambleton Pharmacy Mon, Tue, Thur, Fri Wed Sat Lytham Primary Care Centre Warton Street Lytham FY8 5EE Telephone Mon-Fri Kiln Lane Poulton le Fylde Hambleton FY6 9AH Telephone Mon Tue-Fri Sat Closed daily for lunch Mon - Fri Sat Out Of Hours Access to End of Life Drugs (for use in EMERGENCIES only) Fylde Coast Medical Services via Urgent Care Centre at Blackpool Teaching Hospital, Whinney Heys Road, Blackpool Preston Primary Care Centre Royal Preston Hospital Sharoe Green Lane, Preston

Supporting Last Days of Life Symptom Control Medication Guidance: Algorithm. Agitation & Anxiety

Supporting Last Days of Life Symptom Control Medication Guidance: Algorithm. Agitation & Anxiety Agitation & Anxiety (Exclude or treat REVERSIBLE causes*) Patient is anxious / frightened, but lucid Patient is confused, agitated and / or hallucinating MIDAZOLAM 2.5-5mg s/c (Max total 24 hour dose of

More information

PRESCRIBING GUIDELINES FOR SYMPTOM MANAGEMENT IN THE DYING PATIENT

PRESCRIBING GUIDELINES FOR SYMPTOM MANAGEMENT IN THE DYING PATIENT PRESCRIBING GUIDELINES FOR SYMPTOM MANAGEMENT IN THE DYING PATIENT A collaboration between: St. Rocco s Hospice, Bridgewater Community Healthcare NHS Trust, NHS Warrington Clinical Commissioning Group,

More information

[Type text] Anticipatory Medication STAT dose and Syringe Driver Guidance [Type text]

[Type text] Anticipatory Medication STAT dose and Syringe Driver Guidance [Type text] [Type text] Anticipatory Medication STAT dose and Syringe Driver Guidance [Type text] Patients with egfr greater than 30mL/min Patients with egfr less than 30mL/min Symptom Drug Dose Symptom Drug Dose

More information

PAIN MANAGEMENT Patient established on oral morphine or opioid naive.

PAIN MANAGEMENT Patient established on oral morphine or opioid naive. PAIN MANAGEMENT Patient established on oral morphine or opioid naive. Important; It is the responsibility of the prescriber to ensure that guidelines are followed when prescribing opioids. Every member

More information

PAIN MANAGEMENT Person established taking oral morphine or opioid naive.

PAIN MANAGEMENT Person established taking oral morphine or opioid naive. PAIN MANAGEMENT Person established taking oral morphine or opioid naive. Important; it is the responsibility of the prescriber to ensure that guidelines are followed when prescribing opioids. Every member

More information

End of life prescribing guidance

End of life prescribing guidance End of life prescribing guidance Introduction This guidance has been prepared to ASSIST IN DECISION MAKING for the prescribing and monitoring of medicines useful in the management of symptoms commonly

More information

SYRINGE DRIVER MEDICATIONS

SYRINGE DRIVER MEDICATIONS SYRINGE DRIVER MEDICATIONS Christine Hull & Anita Webb Staff Nurses, Hospice in the Home 2015 Analgesics:- Groups of Medication used in Syringe Drivers Morphine sulphate Diamorphine Oxycodone Alfentanil

More information

Care of the Dying. For dosing in severe renal impairment see separate guidance for care of the dying in severe renal failure.

Care of the Dying. For dosing in severe renal impairment see separate guidance for care of the dying in severe renal failure. Care of the Dying Early diagnosis of the dying process allows for adequate preparation of the patient, the family and the carers. This clinical guidance covers the prescribing and management of patients

More information

Anticipatory Medications for End of Life Patients. Doses must be proportional to the current analgesic medication YES NO YES NO

Anticipatory Medications for End of Life Patients. Doses must be proportional to the current analgesic medication YES NO YES NO Anticipatory Medications for End of Life Patients oses must be proportional to the current analgesic medication Please refer ALL patients on Methadone or Ketamine to palliative care team for advice. Patients

More information

Diamorphine 4 hour. alfentanil (500microgram/mL) Calculated by dividing 24 hour oral morphine dose by 30

Diamorphine 4 hour. alfentanil (500microgram/mL) Calculated by dividing 24 hour oral morphine dose by 30 If more information is required please seek help from specialist palliative care pioid dose conversion chart, syringe driver doses, rescue/prn doses and opioid patches Use the conversion chart to work

More information

Algorithms for Symptom Management. In End of Life Care

Algorithms for Symptom Management. In End of Life Care Algorithms for Symptom Management In End of Life Care The Use of Drugs Beyond Licence (off label) -The Medicines and Healthcare Products Regulatory Agency (MHRA) in the UK regulates the activity of the

More information

ANTICIPATORY PRESCRIBING FOR PATIENTS AT END OF LIFE WITH RENAL IMPAIRMENT

ANTICIPATORY PRESCRIBING FOR PATIENTS AT END OF LIFE WITH RENAL IMPAIRMENT ANTICIPATORY PRESCRIBING FOR PATIENTS AT END OF LIFE WITH RENAL Doses of opiates must be proptional to current analgesic medication Please refer ALL patients on Methadone Ketamine to SPCT f advice. Patients

More information

For patients and their carers this means smoother symptom control, better support in a crisis, and avoidance of admission if that is their choice.

For patients and their carers this means smoother symptom control, better support in a crisis, and avoidance of admission if that is their choice. Bedfordshire Palliative Care Palliative Care Medicines Guidance This folder has been produced to support professionals providing palliative care in any setting. Its aim is to make best practice in palliative

More information

Community Pharmacy Enhanced Service. Just In Case 4 Core Drugs supply. Stock Holding of Palliative Care Medicines

Community Pharmacy Enhanced Service. Just In Case 4 Core Drugs supply. Stock Holding of Palliative Care Medicines Community Pharmacy Enhanced Service Just In Case 4 Core Drugs supply Stock Holding of Palliative Care Medicines Parties to the Agreement Provider: Purchaser: NHS Blackpool 1. Service description 1.1 This

More information

GUIDELINES FOR PRESCRIBING AT THE END OF LIFE FOR PATIENTS WITH RENAL IMPAIRMENT (estimated glomerular filtration rate<30)

GUIDELINES FOR PRESCRIBING AT THE END OF LIFE FOR PATIENTS WITH RENAL IMPAIRMENT (estimated glomerular filtration rate<30) GUIDELINES FOR PRESCRIBING AT THE END OF LIFE FOR PATIENTS WITH RENAL IMPAIRMENT These guidelines have been produced in collaboration with Dr Lucy Smyth, Consultant in Renal Medicine, Royal Devon and Exeter

More information

Care of the Dying Management in Severe Renal Failure

Care of the Dying Management in Severe Renal Failure Care of the Dying Management in Severe Renal Failure Clinical Guideline Early diagnosis of the dying process allows for adequate preparation of the patient, the family and the carers. This clinical guidance

More information

Care of the Dying Management in Severe Renal Failure

Care of the Dying Management in Severe Renal Failure Care of the Dying Management in Severe Renal Failure Clinical Guideline Early recognition of the dying process allows for adequate preparation of the patient, the family and the carers. This clinical guidance

More information

Syringe driver in Palliative Care

Syringe driver in Palliative Care Syringe driver in Palliative Care Introduction: Syringe drivers are portable, battery operated devices widely used in palliative care to deliver medication as a continuous subcutaneous infusion over 24

More information

EAST LANCASHIRE GUIDELINES FOR THE MANAGEMENT OF SYMPTOMS IN THE LAST DAYS OF LIFE

EAST LANCASHIRE GUIDELINES FOR THE MANAGEMENT OF SYMPTOMS IN THE LAST DAYS OF LIFE EAST LANCASHIRE SPECIALIST PALLIATIVE CARE TEAM EAST LANCASHIRE GUIDELINES FOR THE MANAGEMENT OF SYMPTOMS IN THE LAST DAYS OF LIFE Reviewed and updated August 2009 Next review date August 2011 Approved

More information

PENNINE LANCASHIRE GUIDELINES FOR THE MANAGEMENT OF SYMPTOMS IN THE LAST DAYS OF LIFE

PENNINE LANCASHIRE GUIDELINES FOR THE MANAGEMENT OF SYMPTOMS IN THE LAST DAYS OF LIFE PENNINE LANCASHIRE GUIDELINES FOR THE MANAGEMENT OF SYMPTOMS IN THE LAST DAYS OF LIFE Originally produced: July 2006 First Review: August 2009 Second Review: November 2011 For review November 2013 Approved

More information

Renal Palliative Care Last Days of Life

Renal Palliative Care Last Days of Life Renal Palliative Care Last Days of Life Introduction This guideline is an aid to clinical decision-making and good practice for patients with stage 4-5 chronic kidney disease (egfr

More information

MMG035 Symptom Management Guidelines for a Person thought to be in the Last Few Days and Hours of Life

MMG035 Symptom Management Guidelines for a Person thought to be in the Last Few Days and Hours of Life MMG035 Symptom Management Guidelines for a Person thought to be in the Last Few Days and Hours of Life The following pages are guidelines for the management of common symptoms for a person thought to be

More information

ALLERGIES/ SENSITIVITIES This section must be completed before prescribing/administering any drug

ALLERGIES/ SENSITIVITIES This section must be completed before prescribing/administering any drug COMMUNITY PRESCRIPTION CHART All entries should be in CAPITAL letters and in indelible black ink. If medications/ doses are stopped, cross through the relevant line clearly to avoid error. GP: PRESCRIBER

More information

Supportive Care. End of Life Phase

Supportive Care. End of Life Phase Supportive Care End of Life Phase Guidelines for Health Care Professionals In the care of patients with established renal failure who are in the last days of life References: Chambers E J (2004) End of

More information

Care in the Last Days of Life

Care in the Last Days of Life Care in the Last Days of Life Introduction This guideline is an aid to clinical decision making and good practice in person-centred care for patients who are deteriorating and at risk of dying. The patient

More information

PHARMACY SERVICE ARRANGEMENTS FOR THE SUPPLY OF PALLIATIVE CARE SYRINGES AND MEDICINES FOR COMMUNITY PATIENTS

PHARMACY SERVICE ARRANGEMENTS FOR THE SUPPLY OF PALLIATIVE CARE SYRINGES AND MEDICINES FOR COMMUNITY PATIENTS PHARMACY SERVICE ARRANGEMENTS FOR THE SUPPLY OF PALLIATIVE CARE SYRINGES AND MEDICINES FOR COMMUNITY PATIENTS The benefits of prefilled syringes for palliative care from the hospital pharmacy service In

More information

PAIN AND SYMPTOM MANAGEMENT GUIDANCE IN THE LAST DAYS OF LIFE

PAIN AND SYMPTOM MANAGEMENT GUIDANCE IN THE LAST DAYS OF LIFE PAIN AND SYMPTOM MANAGEMENT GUIDANCE IN THE LAST DAYS OF LIFE Reference: DCM029 Version: 1.1 This version issued: 07/06/18 Result of last review: Minor changes Date approved by owner (if applicable): N/A

More information

Guidelines: EOLC Symptom Control for Patients with Normal Renal Function (in Wandsworth)

Guidelines: EOLC Symptom Control for Patients with Normal Renal Function (in Wandsworth) Guidelines: EOLC Symptom Control for Patients with Normal Renal Function (in Wandsworth) Policy Number : DC020 Issue Date: October 2014 Review date: October 2016 Policy Owner: Head Community Services Monitor:

More information

Symptom Management Guidelines for End of Life Care

Symptom Management Guidelines for End of Life Care Symptom Management Guidelines for End of Life Care The following pages are guidelines for the management of common symptoms in the last few days of life. General principles: 1. Consider how symptoms can

More information

End Stage Liver Disease Regional Audit Casenote Survey

End Stage Liver Disease Regional Audit Casenote Survey 1. This questionnaire is an audit of clinical documentation of patients who have died of end stage liver disease. If you have any questions about how this form should be completed please contact Dr Grace

More information

Isle of Wight Syringe Driver Compatibility Guidelines

Isle of Wight Syringe Driver Compatibility Guidelines Isle of Wight Syringe Driver Compatibility Guidelines Produced by The Earl Mountbatten Hospice, Isle of Wight Written January 2015, revision due January 2018 This guideline is available as a paper pocketbook

More information

Access to Palliative Care Drugs and Advice through Lothian Primary Care NHS Trust Community Pharmacy Palliative Care Network

Access to Palliative Care Drugs and Advice through Lothian Primary Care NHS Trust Community Pharmacy Palliative Care Network Access to Palliative Care Drugs and Advice through Lothian Primary Care NHS Trust Community Pharmacy Palliative Care Network Information for GPs, community pharmacists and district nurses First issued

More information

SYMPTOM MANAGEMENT GUIDANCE FOR PATIENTS RECEIVING PALLIATIVE CARE AT ROYAL DERBY HOSPITAL

SYMPTOM MANAGEMENT GUIDANCE FOR PATIENTS RECEIVING PALLIATIVE CARE AT ROYAL DERBY HOSPITAL SYMPTOM MANAGEMENT GUIDANCE FOR PATIENTS RECEIVING PALLIATIVE CARE AT ROYAL DERBY HOSPITAL If a patient is believed to be approaching the end of their life, medication should be prescribed in anticipation

More information

Palliative Care Impact Survey

Palliative Care Impact Survey September 2018 Contents Introduction...3 Headlines...3 Approach...4 Findings...4 Which guideline are used...4 How and where the guidelines are used...6 Alternative sources of information...7 Use of the

More information

BACKGROUND Measuring renal function :

BACKGROUND Measuring renal function : A GUIDE TO USE OF COMMON PALLIATIVE CARE DRUGS IN RENAL IMPAIRMENT These guidelines bring together information and recommendations from the Palliative Care formulary (PCF5 ) BACKGROUND Measuring renal

More information

GUIDELINES ON THE MANAGEMENT OF PAIN DUE TO CANCER IN ADULTS

GUIDELINES ON THE MANAGEMENT OF PAIN DUE TO CANCER IN ADULTS GUIDELINES ON THE MANAGEMENT OF PAIN DUE TO CANCER IN ADULTS Bristol Palliative Care Collaborative Contact Numbers: Hospital Specialist Palliative Care Teams: North Bristol 0117 4146392 UH Bristol 0117

More information

Essential Syringe Driver Training for T 34. Elaine Bird St Luke s Hospice

Essential Syringe Driver Training for T 34. Elaine Bird St Luke s Hospice Essential Syringe Driver Training for T 34 Elaine Bird St Luke s Hospice Aim For all practitioners to be accountable for their individual competence and capability when caring for a resident with a T34

More information

Doncaster & Bassetlaw Cancer Locality. Palliative Care Core Formulary

Doncaster & Bassetlaw Cancer Locality. Palliative Care Core Formulary Doncaster & Bassetlaw Cancer Locality Palliative Core Formulary Approved by Doncaster & Bassetlaw Hospitals NHS Foundation Trust Drugs and Therapeutics Committee. DJ14/2155 Oct 2014 Review date: Oct 2017

More information

Palliative care for heart failure patients. Susan Addie

Palliative care for heart failure patients. Susan Addie Palliative care for heart failure patients Susan Addie Treatments The most common limiting and distressing complaint is of fatigue and breathlessness. Optimal treatment strategies relieve symptoms, improves

More information

Conservative Management of Uraemia

Conservative Management of Uraemia Conservative Management of Uraemia Information for Health Professionals Renal Department The York Hospital and Scarborough Hospital Tel: 01904 725370 For more information, please contact: The Renal Specialist

More information

Anticipatory prescribing and end of life considerations. Dr Stephanie Lippett

Anticipatory prescribing and end of life considerations. Dr Stephanie Lippett Anticipatory prescribing and end of life considerations Dr Stephanie Lippett contents Pain Restlessness/agitation Nausea/vomiting Secretions Syringe driver Anticipatory prescribing Important things to

More information

This survey aims to look at individual practice and can be completed by any healthcare professional.

This survey aims to look at individual practice and can be completed by any healthcare professional. This survey aims to look at individual practice and can be completed by any healthcare professional. If you have any questions about how this form should be completed please contact Dr Grace Ting (ghlting@doctors.net.uk)

More information

We would like to thank you for completing this audit questionnaire which looks at how you manage nausea and vomiting in palliative care patients.

We would like to thank you for completing this audit questionnaire which looks at how you manage nausea and vomiting in palliative care patients. We would like to thank you for completing this audit questionnaire which looks at how you manage nausea and vomiting in palliative care patients. The closing date for responses is 19th December The results

More information

Palliative Care Out-of-hours. A resource pack for West Dorset. Contents:

Palliative Care Out-of-hours. A resource pack for West Dorset. Contents: Palliative Care Out-of-hours. A resource pack for West Dorset Contents: Section 1 Supply of drugs DCH Pharmacy hours and arrangements How to contact a community pharmacist out of hours Palliative care

More information

Policy/Standard Operating Procedure/ Clinical Guideline. ELHT/CP22 Version 5.1. ELHT/CP22 Version 4.1

Policy/Standard Operating Procedure/ Clinical Guideline. ELHT/CP22 Version 5.1. ELHT/CP22 Version 4.1 TRUST WIDE/DIVISIONAL DOCUMENT Delete as appropriate Policy/Standard Operating Procedure/ Clinical Guideline DOCUMENT TITLE: Policy and Procedure for the T34 Ambulatory Syringe Pump in adults (Palliative

More information

Coversheet for Network Site Specific Group Agreed Documentation

Coversheet for Network Site Specific Group Agreed Documentation Coversheet for Network Site Specific Group Agreed Documentation This sheet is to accompany all documentation agreed by Pan Birmingham Cancer Network Site Specific Groups. This will assist the Network Governance

More information

PCA PRESCRIPTION is valid for a maximum of 4 days unless ceased earlier. Date: BINDING MARGIN - NO WRITING BINDING MARGIN - NO WRITING

PCA PRESCRIPTION is valid for a maximum of 4 days unless ceased earlier. Date: BINDING MARGIN - NO WRITING BINDING MARGIN - NO WRITING Attach ADR Sticker THESE INSTRUCTIONS EXPLAIN WHEN TO MAKE A CLINICAL REVIEW OR RAPID RESPONSE CALL, YOUR LOCAL ESCALATION PROTOCOL WILL EXPLAIN HOW TO MAKE A CALL PCA ALLERGIES & ADVERSE DRUG REACTIONS

More information

SYMPTOM CONTROL IN THE LAST DAYS OF LIFE. Bradford, Airedale, Wharfedale & Craven

SYMPTOM CONTROL IN THE LAST DAYS OF LIFE. Bradford, Airedale, Wharfedale & Craven Bradford, Airedale, Wharfedale & Craven Managed Clinical Network SYMPTOM CONTROL IN THE LAST DAYS OF LIFE Guidelines for Healthcare Professionals Bradford, Airedale, Wharfedale & Craven Signs and symptoms

More information

Using syringe pumps in palliative care

Using syringe pumps in palliative care Using syringe pumps in palliative care Facilitator: Barbara Stone RN Ground rules Medication matching game Learning outcomes To identify the indications for using a syringe pump To discuss the general

More information

Berkshire Adult Palliative Care Guidelines - End of Life Care GL110

Berkshire Adult Palliative Care Guidelines - End of Life Care GL110 Berkshire Adult Palliative Care Guidelines - End of Life Care GL110 Approval Approval Group Job Title, Chair of Committee Date Drugs & Therapeutic Committee Chair, Drugs & Therapeutic Committee October

More information

MND Just in Case kit Information for GPs

MND Just in Case kit Information for GPs MND Just in Case kit Information for GPs What is the MND Just in Case kit? 2 Motor neurone disease (MND) is a progressive and terminal disease that results in degeneration of the motor neurones in the

More information

End of Life Care. Dr Anne Garry Consultant in Palliative Medicine

End of Life Care. Dr Anne Garry Consultant in Palliative Medicine End of Life Care Dr Anne Garry Consultant in Palliative Medicine Concerns voiced both by public and professionals.. Implementation and on-going training highly variable across country Decisions made by

More information

Regional Renal Training

Regional Renal Training Regional Renal Training Palliative and End of Life Care Dr Clare Kendall North Bristol NHS Trust Advanced Kidney Disease Dialysis/Transplant Conservative Management Deteriorating despite dialysis/failing

More information

Waterloo Wellington (WW) Symptom Management Guideline for the End of Life (EOL) Medication Order Set for Long Term Care (LTC)

Waterloo Wellington (WW) Symptom Management Guideline for the End of Life (EOL) Medication Order Set for Long Term Care (LTC) Waterloo Wellington (WW) Symptom Management Guideline for the End of Life (EOL) Medication Order Set for Long Term Care (LTC) May 2018 THE WATERLOO WELLINGTON SYMPTOM MANAGEMENT GUIDELINE FOR THE END OF

More information

Care of dying adults in the last days of life. Improving care at the very end of life.

Care of dying adults in the last days of life. Improving care at the very end of life. Care of dying adults in the last days of life Improving care at the very end of life. Foreword We will all experience death, whether it is our own or that of a loved one. The bereaved person s perception

More information

SCHEDULE 2 THE SERVICES

SCHEDULE 2 THE SERVICES SCHEDULE 2 THE SERVICES A. Service Specifications Mandatory headings 1 4: mandatory but detail for local determination and agreement Optional headings 5-7: optional to use, detail for local determination

More information

What s New 2003? What new treatments? What have you discontinued? More information please!

What s New 2003? What new treatments? What have you discontinued? More information please! What s New 2003? What new treatments? What have you discontinued? More information please! 1 What s New 2003? Submissions = 137 UK = 52 (38%) Doctors = 60% Nurses = 25% Pharmacists = 15% 2 What s New?

More information

Analgesia. This is widely used in palliative care. It has antipyretic and analgesic effects but no anti-

Analgesia. This is widely used in palliative care. It has antipyretic and analgesic effects but no anti- Page 1 of 8 Analgesia The World Health Organisation (WHO, 1990) has devised a model to assist health care professionals in the management of cancer pain. The recommendations include managing pain, by the

More information

Prescribing Examples: Basics

Prescribing Examples: Basics Prescribing Examples: Basics 7 0 Pregabolin 5 50mg 05.. 5 6 7 8 9 5 6 5 5 5 5 50 50 50 50 75 75 RF RF RF RF RF RF 5 5 5 5 50 50 50 PJ TF PJ PJ TF TF TF 50 75 75 75 75 TF A: REGULAR PRERIPTION SHEET 5 6

More information

Implementing the recommendation on medication management and symptom control

Implementing the recommendation on medication management and symptom control Implementing the recommendation on medication management and symptom control Mike Grocott Professor of Anaesthesia and Critical Care Medicine University of Southampton Consultant in Critical Care Medicine

More information

The last days of life in hospital and at home

The last days of life in hospital and at home The last days of life in hospital and at home Beaumont Multi-disciplinary Palliative Care Study Day 28/9/2017 Dr Sarah McLean Consultant in Palliative Medicine St Francis Hospice Beaumont Hospital Overview

More information

Clatterbridge Centre for Oncology

Clatterbridge Centre for Oncology Clatterbridge Centre for Oncology CONTENTS 1. Why and when to use a syringe driver 2. Siting the syringe driver 3. Mixing and measuring 4. Setting up the syringe driver 5. Drug information 6. Common problems

More information

PAEDIATRIC DOSAGE GUIDELINES For management of post-operative acute pain

PAEDIATRIC DOSAGE GUIDELINES For management of post-operative acute pain Index No: MMG43 PAEDIATRIC DOSAGE GUIDELINES For management of post-operative acute pain Version: 3.1 (Includes anti-emetics and naloxone) Date ratified: July 2013 Ratified by: (Name of Committee) Name

More information

Drug Prescription and Administration Record

Drug Prescription and Administration Record Chart No. this admission Drug Prescription and Administration Record Patient s Name: of Admission: Chart Start : Chart Finish : NHS No: Consultant Code: Ward: ALERT: of Birth: ADDITIONAL CAUTIONS FOR PRESCRIBING

More information

GUIDELINES FOR CONVERSION FROM A STRONG OPIOID TO METHADONE

GUIDELINES FOR CONVERSION FROM A STRONG OPIOID TO METHADONE GUIDELINES FOR CONVERSION FROM A STRONG OPIOID TO METHADONE GENERAL PRINCIPLES Methadone may be used as a strong opioid alternative when severe cancer-related pain responds poorly to other opioids, or

More information

INTEGRATED CARE PATHWAY (ICP) FOR THE DYING ADULT

INTEGRATED CARE PATHWAY (ICP) FOR THE DYING ADULT INTEGRATED CARE PATHWAY (ICP) FOR THE DYING ADULT PLEASE INFORM THE PALLIATIVE CARE TEAM ON COMMENCEMENT OF THIS ICP (EXT 8958) ICP Start Date Patient s Name. Ward. Consultant.. Named Specialist Nurse

More information

Mid Essex Locality Guideline for Management of Adult Acute and Chronic Non-Cancer Pain in Primary care

Mid Essex Locality Guideline for Management of Adult Acute and Chronic Non-Cancer Pain in Primary care Guideline for Management of Adult Acute and Chronic Non-Cancer Pain in Primary care If possible patients should be assessed using a simple visual analogue scale VAS to determine the most appropriate stage

More information

Overview of Essentials of Pain Management. Updated 11/2016

Overview of Essentials of Pain Management. Updated 11/2016 0 Overview of Essentials of Pain Management Updated 11/2016 1 Overview of Essentials of Pain Management 1. Assess pain intensity on a 0 10 scale in which 0 = no pain at all and 10 = the worst pain imaginable.

More information

Palliative Prescribing - Pain

Palliative Prescribing - Pain Palliative Prescribing - Pain LAURA BARNFIELD 21/2/17 Aims To understand the classes of painkillers available in palliative care To gain confidence in counselling regarding opiates To gain confidence prescribing

More information

BJF Acute Pain Team Formulary Group

BJF Acute Pain Team Formulary Group Title Analgesia Guidelines for Acute Pain Management (Adults) in BGH Document Type Issue no Clinical guideline Clinical Governance Support Team Use Issue date April 2013 Review date April 2015 Distribution

More information

Syringe Drivers. Back to top

Syringe Drivers. Back to top Page 1 of 8 Syringe Drivers Introduction Indications for use Advantages Method Siting syringe driver Boost facility Transfer to hospital/hospice syringe driver drugs Drug compatibility P.r.n medication

More information

NEUROPATHIC CANCER PAIN STANDARDS AND GUIDELINES

NEUROPATHIC CANCER PAIN STANDARDS AND GUIDELINES NEUROPATHIC CANCER PAIN STANDARDS AND GUIDELINES GENERAL PRINCIPLES Neuropathic pain may be relieved in the majority of patients by multimodal management A careful history and examination are essential.

More information

In our patients the cause of seizures can be broadly divided into structural and systemic causes.

In our patients the cause of seizures can be broadly divided into structural and systemic causes. Guidelines for the management of Seizures Amalgamation and update of previous policies 7 (Seizure guidelines, ND, 2015) and 9 (Status epilepticus, KJ, 2011) Seizures can occur in up to 15% of the Palliative

More information

Palliative Care Formulary

Palliative Care Formulary Palliative Care Formulary 2016-2019 This formulary for pain and symptom management in adults is intended as a guide for prescribers in hospital and community. Special care should be taken when prescribing

More information

CCR-BPD020 BERKSHIRE ADULT PALLIATIVE CARE GUIDELINES. SECTION 3: End of Life Symptom Control. Berkshire Healthcare NHS Foundation Trust

CCR-BPD020 BERKSHIRE ADULT PALLIATIVE CARE GUIDELINES. SECTION 3: End of Life Symptom Control. Berkshire Healthcare NHS Foundation Trust CCR-BPD020 BERKSHIRE ADULT PALLIATIVE CARE GUIDELINES SECTION 3: End of Life Symptom Control Berkshire Healthcare NHS Foundation Trust Did you print this document yourself? Please be advised that the Trust

More information

1. GUIDELINES FOR THE MANAGEMENT OF AGITATION IN ADVANCED CANCER

1. GUIDELINES FOR THE MANAGEMENT OF AGITATION IN ADVANCED CANCER 1. GUIDELINES FOR THE MANAGEMENT OF AGITATION IN ADVANCED CANCER 1.1 GENERAL PRINCIPLES There are many causes of agitation in palliative care patients, which makes recommendations for treatment difficult.

More information

Respiratory Secretions. Care in the last 72 hours of life Paul Tait, pharmacist

Respiratory Secretions. Care in the last 72 hours of life Paul Tait, pharmacist Respiratory Secretions Care in the last 72 hours of life Paul Tait, pharmacist 50% Why? Inability to swallow & clear secretions Ineffective cough Reduced consciousness Pooling of secretions in the throat

More information

Palliative Care and the Critical Role of the Pharmacist. Arti Thakerar Education/ Palliative Care Peter MacCallum Cancer Centre

Palliative Care and the Critical Role of the Pharmacist. Arti Thakerar Education/ Palliative Care Peter MacCallum Cancer Centre Palliative Care and the Critical Role of the Pharmacist Arti Thakerar Education/ Palliative Care Peter MacCallum Cancer Centre Overview What is palliative care Role of a pharmacist in palliative care Issues

More information

survey Parenteral anti-epileptics What is your experience? May July 2015

survey Parenteral anti-epileptics What is your experience? May July 2015 Parenteral anti-epileptics What is your experience? May July 2015 Number of responses = 99 1a) In patients with pre-existing epilepsy controlled by PO medication that are imminently dying (prognosis

More information

Alternative Routes of Drug Administration (analgesia) Dr Andrew Dickman Consultant Pharmacist

Alternative Routes of Drug Administration (analgesia) Dr Andrew Dickman Consultant Pharmacist Alternative Routes of Drug Administration (analgesia) Dr Andrew Dickman Consultant Pharmacist Alternative Routes of Drug Administration Introduction Subcutaneous Route Contemporary Issues Compatibility

More information

Berkshire West Area Prescribing Committee Guidance

Berkshire West Area Prescribing Committee Guidance Guideline Name Berkshire West Area Prescribing Committee Guidance Date of Issue: September 2015 Review Date: September 2017 Date taken to APC: 2 nd September 2015 Date Ratified by GP MOC: Guidelines for

More information

CARE OF THE DYING PATIENT WITH ESKD ELIZABETH JOSLAND - RSC CNC

CARE OF THE DYING PATIENT WITH ESKD ELIZABETH JOSLAND - RSC CNC CARE OF THE DYING PATIENT WITH ESKD ELIZABETH JOSLAND - RSC CNC OBJECTIVES UNDERSTANDING OF: POTENTIAL COMPLEXITIES OF ESKD PATIENTS IMPORTANCE OF COMMUNICATION CONSIDERATIONS AT END-OF-LIFE END-OF-LIFE

More information

BREATHLESSNESS MANAGEMENT

BREATHLESSNESS MANAGEMENT Guideline Name: Breathlessness BACKGROUND Breathlessness is a common symptom in patients with cancer, end-stage heart failure and end-stage chronic obstructive pulmonary disease (COPD). There are many

More information

Morphine and strong opioid information

Morphine and strong opioid information Morphine and strong opioid information MY Medicines Helpline: 01924 541398 Monday to Friday 9am to 5pm Use this space for patient ID label Name: DOB: NHS Number: Hospital Number: The mere mention of Morphine

More information

Treating the symptoms of kidney failure

Treating the symptoms of kidney failure Treating the symptoms of kidney failure Information for patients, relatives and carers Renal Department The York Hospital and Scarborough Hospital Tel: 01904 725370 For more information, please contact:

More information

Palliative Care. Pocketbook 4

Palliative Care. Pocketbook 4 Nottinghamshire STP EOL Programme Board 2019 Review 2022 Palliative Care Pocketbook 4 Contents Pain Guidelines page 2 Nausea and Vomiting page 9 Inoperable Bowel Obstruction page 10 Constipation page 11

More information

PALLIATIVE CARE PRESCRIBING FOR PATIENTS WHO ARE SUBSTANCE MISUSERS

PALLIATIVE CARE PRESCRIBING FOR PATIENTS WHO ARE SUBSTANCE MISUSERS PALLIATIVE CARE PRESCRIBING FOR PATIENTS WHO ARE SUBSTANCE MISUSERS Background information Substance misusers who develop palliative care needs are likely to have psychological, social and existential

More information

Ketorolac injection. Supportive care

Ketorolac injection. Supportive care Supportive care Ketorolac injection Supportive care: specialist medicines This leaflet provides information on a medicine called ketorolac which is used to treat pain that is difficult to control. It is

More information

Child and Adolescent Mental Health Services (CAMHS) in Lancashire Q&A

Child and Adolescent Mental Health Services (CAMHS) in Lancashire Q&A Child and Adolescent Mental Health Services (CAMHS) in Lancashire Q&A 2 3 Child and Adolescent Mental Health Services (CAMHS) in Lancashire Q&A Do you have concerns about the emotional health of the children

More information

ADULT (>16) ACUTE SICKLE PAIN GUIDELINE

ADULT (>16) ACUTE SICKLE PAIN GUIDELINE ADULT (>16) ACUTE SICKLE PAIN GUIDELINE ID 2013 065 Author s Name Dr Anna Wood Author s Job Title Consultant Haematologist Division Consultant Haematologist Department Haematology Version number 3 Ratifying

More information

Lothian Palliative Care Guidelines POCKET EDITION 2004

Lothian Palliative Care Guidelines POCKET EDITION 2004 Lothian Palliative Care Guidelines POCKET EDITION 2004 These guidelines have been developed by a multidisciplinary group of specialist and non-specialist health professionals from hospital, community and

More information

Palliative care for patients with brain cancer

Palliative care for patients with brain cancer Palliative care for patients with brain cancer Lyn Cave Clinical Nurse Specialist Palliative Care Hospital2Home (H2H) Dr Jayne Wood Clinical Lead Palliative Care The Royal Marsden and Royal Brompton Palliative

More information

Palliative Care. Anticipatory Prescribing Guidelines & June Gippsland Region Palliative Care Consortium Clinical Practice Group

Palliative Care. Anticipatory Prescribing Guidelines & June Gippsland Region Palliative Care Consortium Clinical Practice Group Palliative Care Anticipatory Prescribing Guidelines June 2016 Gippsland Region Palliative Care Consortium Clinical Practice Group Policy No. Title Keywords Ratified GRPCC-CPG008_1.1_2016 Anticipatory Prescribing

More information

The Mid Yorkshire Macmillan Specialist Palliative Care Team

The Mid Yorkshire Macmillan Specialist Palliative Care Team The Mid Yorkshire Macmillan Specialist Palliative Care Team Morphine and Strong Opioid information leaflet Information for patients/carers The mere mention of Morphine can be enough to conjure up all sorts

More information

Approach to symptom control near the end-of-life

Approach to symptom control near the end-of-life Approach to symptom control near the end-of-life 18 Sept 2011 Dr Alethea Yee Senior Consultant, Department of Palliative Medicine National Cancer Centre,Singapore What is end of life? No precise definition

More information

Long Term Care Formulary HCD - 08

Long Term Care Formulary HCD - 08 1 of 5 PREAMBLE Opioids are an important component of the pharmaceutical armamentarium for management of chronic pain. The superiority of analgesic effect of one narcotic over another is not generally

More information

PEDIATRIC SPINE SURGERY POST-OP PLAN - Phase:.

PEDIATRIC SPINE SURGERY POST-OP PLAN - Phase:. - Phase:. PHYSICIAN S Diagnosis Weight Allergies DETAILS Patient Care Patient Activity Bedrest Maintain Surgical Drain Maintain JP Drain, Measure Output q12h, and PRN Convert IV to INT when tolerating

More information

Pain management in Paediatric Palliative Care. Dr Jane Nakawesi 14 th August 2017

Pain management in Paediatric Palliative Care. Dr Jane Nakawesi 14 th August 2017 Pain management in Paediatric Palliative Care Dr Jane Nakawesi 14 th August 2017 Content Management of pain in children Non pharmacological Pharmacological Exit level outcomes The participants will: Know

More information

PALLIATIVE TREATMENT BY DR. KHRONGKAMOL SIHABAN MEDICAL ONCOLOGIST

PALLIATIVE TREATMENT BY DR. KHRONGKAMOL SIHABAN MEDICAL ONCOLOGIST PALLIATIVE TREATMENT BY DR. KHRONGKAMOL SIHABAN MEDICAL ONCOLOGIST TREATMENT IN ONCOLOGY Main treatment : surgery Neoadjuvant treatment : RT, CMT Adjuvant treatment : Tx micrometastatic disease -CMT,Targeted

More information